ガンマデルタT細胞を介したミノドロン酸の非小細胞肺癌細胞株に対するアポトーシス誘導効果の検討

Background/aim: Non-small cell lung carcinoma (NSCLC) is one of the leading causes of cancer-related death worldwide. Recent studies showed that nitrogen-containing bisphosphonates (N-BPs) directly and indirectly prevent proliferation, induce apoptosis, and inhibit metastasis of various types of cancer cell. In order to investigate the effect of combining minodronic acid (MDA) with γδ T-cells, NSCLC cells were treated with five concentrations of MDA. Materials and methods: NSCLC cells were cultured with different concentrations of MDA alone or in combination with γδ T-cells for 24 h. Results: MDA with γδ T-cells had differential apoptotic effects on the NSCLC cell lines. The cells showed significant apoptotic effects in the presence of MDA in a dose-dependent manner. Conclusion: This study is the first to report an indirect effect of MDA against NSCLC. We report the induction of apoptosis by MDA in combination with γδ T-cells.博士（医学）・乙第1446号・令和元年12月5日Copyright© 2019, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.発行元の規定により、本文の登録不可。本文は以下のURLを参照 "http://dx.doi.org/10.21873/anticanres.11174"（※全文閲覧は学内限定

HASC2011corpus: Towards the Common Ground of Human Activity Recognition

UbiComp '11 Proceedings of the 13th international conference on Ubiquitous computing, September 17-21, 2011, Beijing, ChinaHuman activity recognition through the wearable sensor will enable a next-generation human-oriented biquitous computing. However, most of research on human activity recognition so far is based on small number of subjects, and non-public data. To overcome the situation, we have gathered 4897 accelerometer data with 116 subjects and compose them as HASC2011corpus. In the field of pattern recognition, it is very important to evaluate and to improve the recognition methods by using the same dataset as a common ground. We make the HASC2011corpus into public for the research community to use it as a common ground of the Human Activity Recognition. We also show several facts and results of obtained from the corpus

Vastus lateralis oxygenation during prolonged cycling in healthy males

This study examined the relationship between the acute cardiorespiratory and muscleoxygenation/blood volume changes during prolonged exercise. Eight healthy male volunteers (mean VO2max = 41.6 ± 2.4 ml/kg/min) performed 60 minutes submaximal cycling at 500f VO2max. Oxygen uptake (VO2) was measured by indirect spirometry, cardiac output (CO) was estimated via Portapres, and right vastus lateralis oxyhemoglobin/myoglobin (OxyHb/Mb), deoxyhemoglobin/myoglobin (DeoxyHb/Mb) and total hemoglobin/myoglobin (Total Hb/Mb) were recorded using near infrared spectroscopy. After 40 minutes of exercise, there was a significant increase in VO2 due to a significantly higher (a – v)O2diff. After 30 mins of exercise CO was unchanged, but there was a significant decrease in stroke volume and a proportionate increase in heart rate indicating the occurrence of cardiovascular drift. During the first few minutes of exercise, there was a decline in OxyHb/Mb and Total Hb/Mb while DeoxyHb/Mb remained unchanged. Thereafter OxyHb/Mb and Total Hb/Mb increased systematically until the termination of exercise while DeoxyHb/Mb declined. After 40 minutes of exercise, these changes were significantly different from the baselines values. There were no significant correlations between the changes in the NIRS variables and systemic VO2 or mixed (a – v)O2diff during exercise. These results suggest that factors other than localized changes in muscle oxygenation and blood volume account for the increased VO2 during prolonged submaximal exercise

Long-Term Optical Continuum Color Variability of Nearby Active Galactic Nuclei

We examine whether the spectral energy distribution of optical continuum emission of active galactic nuclei (AGNs) changes during flux variation, based on accurate and frequent monitoring observations of 11 nearby Seyfert galaxies and QSOs carried out in the B, V, and I bands for seven years by the MAGNUM telescope. The multi-epoch flux data in any two different bands obtained on the same night show a very tight linear flux to flux relationship for all target AGNs. The flux of the host galaxy within the photometric aperture is carefully estimated by surface brightness fitting to available high-resolution HST images and MAGNUM images. The flux of narrow emission lines in the photometric bands is also estimated from available spectroscopic data. We find that the non-variable component of the host galaxy plus narrow emission lines for all target AGNs is located on the fainter extension of the linear regression line of multi-epoch flux data in the flux to flux diagram. This result strongly indicates that the spectral shape of AGN continuum emission in the optical region does not systematically change during flux variation. The trend of spectral hardening that optical continuum emission becomes bluer as it becomes brighter, which has been reported by many studies, is therefore interpreted as the domination of the variable component of the nearly constant spectral shape of an AGN as it brightens over the non-variable component of the host galaxy plus narrow lines, which is usually redder than AGN continuum emission.Comment: 47 pages, 29 figures, AASTeX, Accepted for publication in Ap

Japanese subpopulation analysis of MONARCH 2: phase 3 study of abemaciclib plus fulvestrant for treatment of hormone receptor-positive, human epidermal growth factor receptor 2-negative breast cancer that progressed on endocrine therapy

BACKGROUND: This was a Japanese subpopulation analysis of MONARCH 2, a double-blind, randomized, placebo-controlled, phase 3 study of abemaciclib plus fulvestrant in patients with hormone receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer (ABC). METHODS: Eligible women had progressed on (neo)adjuvant endocrine therapy (ET),  ≤ 12 months from end of adjuvant ET, or on first-line ET for ABC, and had not received chemotherapy for ABC. Patients were randomized 2:1 to receive abemaciclib or placebo plus fulvestrant. The primary endpoint was progression-free survival (PFS). Secondary endpoints included overall survival (OS), pharmacokinetics (PK), health-related quality of life (HRQoL), and safety. RESULTS: In Japan, 95 patients were randomized (abemaciclib, n = 64; placebo, n = 31). At final PFS analysis (February 14, 2017), median PFS was 21.2 and 14.3 months, respectively, in the abemaciclib and placebo groups (hazard ratio: 0.672; 95% confidence interval: 0.380-1.189). Abemaciclib had a higher objective response rate (37.5%) than placebo (12.9%). PK and safety profiles for Japanese patients were consistent with those of the overall population, without clinically meaningful differences across most HRQoL dimensions evaluated. The most frequent adverse events in the abemaciclib versus placebo groups were diarrhea (95.2 versus 25.8%), neutropenia (79.4 versus 0%), and leukopenia (66.7 versus 0%). At a second data cutoff (June 20, 2019), median OS was not reached with abemaciclib and 47.3 months with placebo (hazard ratio: 0.755; 95% confidence interval: 0.390-1.463). CONCLUSIONS: Results of the Japanese subpopulation were consistent with the improved clinical outcomes and manageable safety profile observed in the overall population. CLINICAL TRIAL REGISTRATION: NCT02107703; U.S. National Library of Medicine: https://clinicaltrials.gov/ct2/show/NCT02107703

Spontaneous Rupture of Hepatocellular Carcinoma

Of 105 patients of hepatocellular carcinoma (HCC) treated during 1970-1988, twelve patients had spontaneous rupture of carcinomatous nodules. 1) Of previous 6 cases, five were treated by conventional surgical procedures such as packing and suture, and all died. One case underwent right lobectomy following guaze pack and lived for 15 months. 2) The recent 6 cases underwent emergency transcatheter arterial embolization (TAE ) and two died of hepatic failure due to severe cirrhosis. The other 4 cases had successful control , of bleeding which allowed further treatment of HCC ; hepatectomy in 3 and repeated TAE in one. 3) All cases had precirrhosis or cirrhosis. Pathologically, ruptured tumors expansively growing with capsule invasion of cancer cells, and portal tumor thrombus were recognized in resected or autopsy specimens. DNA aneuploid HCC on flow cytometric DNA analysis were found in 4 out of 5 cases. In conclusion, hepatic resection following embolization, when possible, would seem to be rational treatment for spontaneous rupture of HCC, although the prognosis is still extremely poor despite successful control of bleeding